Age at onset of major depressive disorder predicts reductions in NK cell number and activity

Journal of Affective Disorders

Volumn 71, Issue 1-3, 2002, Pages 159-167

  Frank, Matthew G ^a,d   Wieseler Frank, Julie L ^b   Hendricks, Shelton E ^b   Burke, William J ^a   Johnson, Donald R ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Depression; Immune function; NK cell

Indexed keywords

ARTICLE; BIOASSAY; CELL ACTIVITY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DEPRESSION; FLOW CYTOMETRY; HAMILTON SCALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; ONSET AGE; PATHOGENESIS; PATIENT CARE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RATING SCALE; REDUCTION; RELIABILITY; SELF REPORT; SLEEP DISORDER; STANDARD;

ADULT; AGE OF ONSET; DEPRESSIVE DISORDER; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0036345863     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(01)00395-0     Document Type: Article

References (41)

1. Major depression in 1998: Are we providing optimal therapy?
2. Interleukin-1β production in dysthymia before and after pharmacotherapy
3. Endocrine and cytokine correlates of major depression and dysthymia with typical and atypical features
4. Factor analysis of the Hamilton Depression Scale
5. Health psychology: Psychological factors and physical disease from the perspective of human psychoneuroimmunology
6. Immunity and depression: Insomnia, retardation, and reduction of natural killer cell activity
7. Circulating natural killer cell phenotypes in men and women with major depression
8. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects
9. Conceptualization and rationale for consensus definitions of terms in major depressive disorder
10. Antidepressants augment natural killer cell activity: In vivo and in vitro
11. Dysthymia: A review of pharmacological and behavioral factors
12. A rating scale for depression
13. Functioning and well-being outcomes of patients with depression compared with chronic general medical conditions
14. Natural killer cells: Their role in defense against disease
15. Depression and reduced natural killer cytotoxicity: A longitudinal study of depressed patients and control subjects
16. Partial sleep deprivation reduces natural killer cell activity in humans
17. Partial sleep deprivation reduces natural killer cell activity and cellular immune responses in humans
18. Immune correlates in depression
19. Long-term outcome of episodes of major depression
20. Age of onset in chronic major depression: Relation to demographic and clinical variables, family history, and treatment response
21. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule
22. Recurrence after recovery in unipolar MDD: An observational follow-up study of clinical predictors and somatic treatment as a mediating factor
23. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
24. A registry-based twin study of depression in men
25. Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobinemia during major depression
26. Natural killer cell activity in major depression: Relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology
27. Evidence for an immune response in major depression: A review and hypotheses
28. The monocyte-T-lymphocyte hypothesis of major depression
29. The relationship of depression to cardiovascular disease
30. Chronically depressed mood and cancer risk in older persons
31. Minor and major depression and the risk of death in older persons
32. Effect of smoking on human natural killer cell activity
33. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity
34. Melancholic symptom features and DSM-IV
35. Depression, the immune system, and health and illness
36. Three- to 5-year prospective follow-up of outcome in major depression
37. Onset of major depression in early adulthood
38. The functioning and well-being of depressed patients
39. Relation of stressors and depressive symptoms to clinical progression of viral illness